ZNF432 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.787600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.625600E-01
Normal-vs-Stage2
8.645600E-01
Normal-vs-Stage3
4.192200E-02
Normal-vs-Stage4
3.617000E-01
Stage1-vs-Stage2
4.745200E-01
Stage1-vs-Stage3
1.632040E-02
Stage1-vs-Stage4
5.983600E-01
Stage2-vs-Stage3
1.227360E-01
Stage2-vs-Stage4
3.111800E-01
Stage3-vs-Stage4
7.223700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.308600E-01
Normal-vs-AfricanAmerican
5.789800E-01
Normal-vs-Asian
3.238200E-01
Caucasian-vs-AfricanAmerican
6.583200E-01
Caucasian-vs-Asian
1.964200E-01
AfricanAmerican-vs-Asian
5.303600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.983600E-01
Normal-vs-Female
6.477200E-01
Male-vs-Female
1.900210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.345400E-01
Normal-vs-Age(41-60Yrs)
9.521800E-01
Normal-vs-Age(61-80Yrs)
8.574200E-01
Normal-vs-Age(81-100Yrs)
8.889600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.617600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.262200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.599000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.188000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.379200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.381400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.130800E-01
Normal-vs-Daily Drinker
7.248400E-01
Normal-vs-Weekly Drinker
8.954400E-01
Normal-vs-Occasional Drinker
6.309400E-01
Normal-vs-Social Drinker
7.730400E-01
Non Drinker-vs-Daily Drinker
9.932800E-01
Non Drinker-vs-Weekly Drinker
5.393200E-01
Non Drinker-vs-Occasional Drinker
5.310000E-02
Non Drinker-vs-Social Drinker
6.614800E-01
Daily Drinker-vs-Weekly Drinker
6.482200E-01
Daily Drinker-vs-Occasional Drinker
1.464230E-01
Daily Drinker-vs-Social Drinker
7.503000E-01
Weekly Drinker-vs-Occasional Drinker
3.212600E-01
Weekly Drinker-vs-Social Drinker
8.491400E-01
Occasional Drinker-vs-Social Drinker
1.824790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.372370E-01
Normal-vs-Grade 2
5.785500E-02
Normal-vs-Grade 3
1.573640E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.489000E-01
Grade 1-vs-Grade 3
7.652200E-01
Grade 1-vs-Grade 4
1.372370E-01
Grade 2-vs-Grade 3
5.565200E-01
Grade 2-vs-Grade 4
5.785500E-02
Grade 3-vs-Grade 4
1.573640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.495800E-01
Normal-vs-NonDiabetic
8.709600E-01
Diabetic-vs-NonDiabetic
7.788200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.748000E-02
Normal-vs-NoPancreatitis
8.874800E-01
Pancreatitis-vs-NoPancreatitis
1.258370E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.221200E-01
Normal-vs-N1
7.232600E-01
N0-vs-N1
2.494800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.914200E-01
Normal-vs-TP53-NonMutant
9.043600E-01
TP53-Mutant-vs-TP53-NonMutant
2.378000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
